SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-014613
Filing Date
2024-03-21
Accepted
2024-03-21 16:06:58
Documents
19
Period of Report
2024-03-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20024600x3_8-k.htm   iXBRL 8-K 41033
2 EXHIBIT 1.1 ny20024600x3_ex1-1.htm EX-1.1 278041
3 EXHIBIT 5.1 ny20024600x3_ex5-1.htm EX-5.1 16993
4 EXHIBIT 99.1 ny20024600x3_ex99-1.htm EX-99.1 13515
5 EXHIBIT 99.2 ny20024600x3_ex99-2.htm EX-99.2 14502
9 ny20024600x3ex5-1_image01.jpg GRAPHIC 2502
10 ny20024600x3ex99-1_image01.jpg GRAPHIC 2276
  Complete submission text file 0001140361-24-014613.txt   589750

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aqst-20240319.xsd EX-101.SCH 3868
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqst-20240319_lab.xml EX-101.LAB 22690
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqst-20240319_pre.xml EX-101.PRE 16554
23 EXTRACTED XBRL INSTANCE DOCUMENT ny20024600x3_8-k_htm.xml XML 4225
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 24771347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)